
February 27, 2025
by Anne Miller
When I saw this Opinion piece (available on a Creative Commons licence), I thought the ideas discussed were too important not to share with our readers.
Aedes aegypti mosquitoes have been found in the South Burnett in the past, and in 2020 there was a spike in Ross River Fever cases across the Darling Downs Health region linked to this type of mosquito.
Controlling these nasty critters should therefore be considered important, however Dr Perran Stott-Ross lists three reasons why he believes releasing genetically modified Aedes aegypti mosquitoes in Queensland is risky:
- It could undermine current dengue control interventions,
- The genetic modification has not been tested in Australian mosquitoes, and
- The introduction of foreign genetic material has unknown consequences.
There are also a couple of other points to consider:
- Dr Perran Stott-Ross has skin in the game. He studies novel mosquito control technologies including the use of mosquitoes carrying the Wolbachia bacteria which is currently used to control Aedes aegypti populations.
- And controlling Aedes aegypti, while important in stopping the spread of dengue and some other mosquito-borne illnesses, will not stop the spread of Japanese encephalitis virus (JEV) which is the disease currently the focus of a lot of attention in Queensland.
JEV is spread by Culex species mosquitos. In Australia, this is probably Culex annulirostris.
JEV should be of concern to South Burnett residents as we have all the ingredients to make this a problem: lots of pigs (both feral and in piggeries), lots of visiting waterbirds and a very large pig abattoir.
Fortunately, serious cases of JEV infection that require hospitalisation are very, very rare however a man did die of the disease in a Sydney hospital earlier this week.
Authorities believe he contracted JEV after being bitten by a mosquito while holidaying in the Murrumbidgee region of southern NSW in January.
Releasing GM Aedes aegypti won’t remove the risk that JEV poses in Australia …
* * *
by Dr Perran Stott-Ross, University of Melbourne
The British company Oxitec, in partnership with Australia’s CSIRO, has announced plans to release genetically modified (GM) mosquitoes in Queensland.
The initiative aims to reduce transmission of the dengue virus, as well as other pathogens spread by the Aedes aegypti mosquito by reducing the size of the mosquito population.
The announcement has received significant attention from the public – there was even a petition to State Parliament to block the release.
While these mosquitoes are unlikely to cause adverse health impacts as some have suggested, there are still legitimate reasons for concern.
Here are three key reasons why we should be wary of releasing GM mosquitoes in Australia.
How Would It Work?
Only female mosquitoes drink blood to feed their eggs, meaning only female mosquitoes spread disease to humans.
The mosquitoes developed by Oxitec are a Mexican strain of Aedes aegypti, genetically engineered to express a gene that’s lethal to females. This means only male mosquitoes can survive and reproduce in the wild.
Male mosquitoes don’t bite so they can’t spread disease, but they can still mate with wild Australian female mosquitoes and pass on their genes – both the lethal gene and other genes naturally occur in the Mexican strain of Aedes aegypti.
This technique has advantages over similar technologies because it is effective across multiple generations, making the population reduction last longer.
It will also only target Aedes aegypti and won’t affect other mosquito species directly.
The mosquitoes will also carry a fluorescent gene making them easy to identify.
The GM mosquitoes will be sold to businesses and the public, allowing anyone in Queensland to release them on their own property.
They can be raised by adding water to a container and placing it outside. Eventually, male mosquitoes will emerge to mate with the wild population.
The technology is already used overseas with trials showing drastic reductions in mosquito populations, but the situation in Australia is markedly different and so carries different risks.
Releases of GM mosquitoes could undermine current dengue control interventions
Dengue transmission in Queensland is all but eradicated thanks to a successful control program that has now been running for over a decade.

While imported cases of dengue remain common, it doesn’t spread locally because Wolbachia remains at high levels in the mosquito population.
Releasing GM mosquitoes will directly interfere with what is already an effective and ongoing solution to dengue in Queensland.
Unlike Wolbachia, which has little impact on the size of the mosquito population, GM mosquitoes are intended to wipe them out.
This increases the risk that mosquitoes without Wolbachia could establish via accidental introductions (like stowaways) or mosquitoes derived from the GM strain.
The genetic modification has not been tested in Australian mosquitoes
Oxitec has performed rigorous testing to ensure that the genetic modification behaves as expected under a range of conditions.
But they have not tested this in Australia.
Australian populations of Aedes aegypti mosquitoes are distinct from those of other countries, including Mexico, where the GM mosquitoes are derived.
For the GM strain to succeed, the introduced gene must be transmitted at a high frequency and kill all female offspring, to achieve a substantial population reduction. While this was the outcome in Brazil, it remains to be seen whether these effects will be the same in Australian mosquitoes.
On top of this, there’s been no testing of any interactions between the genetic modification and Wolbachia. This is an astonishing oversight given that almost all Aedes aegypti in Queensland carry Wolbachia.
The introduction of foreign genetic material has unknown consequences
While the genetic modification will eventually drop out because any females that remain will no longer carry it, introducing other genetic changes to the Queensland mosquito population is an intended feature of the technology and may be permanent.
The Mexican Aedes aegypti strain will naturally have some different non-GM-introduced genes to the Australian mosquitoes from decades of evolution.
This is a concern because some of these genes could cause undesirable traits like insecticide resistance.
Australian populations of Aedes aegypti are unique in their lack of resistance to common insecticides, a trait widespread elsewhere.
Furthermore, mosquitoes from different parts of the world are adapted to different climates. These differences mean that hybrid mosquitoes could also differ in important ways, with potential consequences for future control efforts.
There have been previous concerns raised about hybrid mosquitoes carrying a different GM strain that caused complete lethality.
While evidence didn’t bear these concerns out, the new strain is a different story as it only kills female mosquitoes.
When Will The Mosquitoes Be Released?
There’s a long road ahead before the release of GM mosquitoes in Queensland.
Stringent regulators must first approve the application. The Office of the Gene Technology Regulator is consulting experts and is set to release a risk assessment for public consultation in late March 2025.
Releases will also be subject to approval by the Australian Pesticides and Veterinary Medicines Authority.
Even more important is gaining public approval.
There are clear benefits of GM mosquitoes, particularly if the technology is expanded to target other mosquito species or if dengue hotspots appear in future.
But this must be balanced against the risks.
In Queensland, there seems little benefit when we already have an effective solution.
There’s still time to address some of the risks raised here. Breeding the genetic modification into Australian mosquitoes prior to any release could help to alleviate concerns about the introduction of foreign genes.
This would allow time for testing to confirm that the intended effects on female lethality also occur in Australian mosquitoes.
This gives us the best chance to eliminate the harmful diseases carried by the Aedes aegypti.
[This article was first published on February 26, 2025 in Pursuit. Read the original article]
- Read more Editorial columns